| Drug Name |
Terbutaline |
| Drug ID |
BADD_D02162 |
| Description |
Terbutaline was first synthesized in 1966[A230333] and described in the literature in the late 1960s and early 1970s.[A230328] It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.[A230333,L32093,L32098]
Terbutaline was granted FDA approval on 25 March 1974.[L32088] |
| Indications and Usage |
For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible, obstructive airway disease, as well as symptomatic management of reversible bronchospasm associated with bronchitis and emphysema. Also used acute IV and sub-Q therapy in selected women to inhibit uterine contractions in preterm labor (tocolysis) and prolong gestation when beneficial. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
R03AC03; R03CC03 |
| DrugBank ID |
DB00871
|
| KEGG ID |
D08570
|
| MeSH ID |
D013726
|
| PubChem ID |
5403
|
| TTD Drug ID |
D0M8RC
|
| NDC Product Code |
Not Available |
| Synonyms |
Terbutaline | Asthmoprotect | Brethaire | Brethine | Bricanyl | Terbasmin | Bricanyl SA | Butaliret | Butalitab | Contimit | KWD-2019 | KWD 2019 | KWD2019 | Monovent | Taziken | Tedipulmo | Terbul | Terbutalin AL | Terbutalin Stada | terbutalin von ct | Terbutalin-ratiopharm | Terbutalin ratiopharm | Terbutaline Sulfate | Terbuturmant | Arubendol |
